The FDA Circulatory System Devices advisory panel early this month grappled with the question of whether a laser alone was as effective in treating patients with blocked arteries as balloon angioplasty and overwhelmingly voted 9-1 against recommending approval of the new indication for Spectranetics’ (Colorado Springs, Colorado) CVX-300 excimer laser system.